
Unmet Needs in Managing Vasomotor Symptoms in Menopause
Panelists discuss how limited treatment options and systemic barriers underscore the urgent need for accessible, targeted therapies for vasomotor symptoms.
Despite advances in understanding vasomotor symptoms, significant gaps remain in effective symptom management. Many patients cannot or prefer not to use hormone therapy, leaving limited options for relief. Additionally, cultural stigmas and lack of awareness often prevent timely diagnosis and treatment, leading to prolonged suffering.
The discussion highlights that current nonhormonal treatments may offer partial relief but often fail to address the full spectrum of menopausal symptoms, including mood, sleep, and cognitive changes. There is a pressing need for safe, well-tolerated alternatives that target root neurobiological mechanisms rather than masking symptoms.
Panelists emphasize that improving access to care, increasing clinician education, and tailoring therapies to diverse patient needs are key priorities. Addressing these unmet needs will help close the gap between emerging science and real-world care for menopausal patients.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.




























































































































































